Page last updated: 2024-08-21

cyclooctane and E coli Infections

cyclooctane has been researched along with E coli Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fukuda, H; Fukuda, Y; Garlisi, CG; Gill, CJ; Kaelin, D; Kishii, R; Lagrutta, A; Meinke, PT; Miesel, L; Nishimura, A; Olsen, DB; Oohata, K; Shibue, T; Singh, SB; Takano, H; Takei, M; Takeuchi, T; Tan, CM; Toussaint, N; Tsuchiya, T; Wu, J; Yin, J	1

Other Studies

1 other study(ies) available for cyclooctane and E coli Infections

Article	Year
In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8 Topics: Animals; Anti-Bacterial Agents; Cell Line; Cyclooctanes; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Dogs; Escherichia coli; Escherichia coli Infections; Humans; Mice; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Topoisomerase II Inhibitors	2016

Article

Year

In Vitro and In Vivo Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA Gyrase.

Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8

Topics: Animals; Anti-Bacterial Agents; Cell Line; Cyclooctanes; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; DNA, Bacterial; Dogs; Escherichia coli; Escherichia coli Infections; Humans; Mice; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Topoisomerase II Inhibitors

2016